Using neuroimaging and mathematical graph theory, researchers discover it is possible to detect those at risk of developing psychosis by examining cortical folding.
A new study that measured autistic and schizophrenic traits in the general population, rather than in those already diagnosed, reveals significant overlaps in traits associated with the disorders. Researchers say people in the general population can be categorized into eight subgroups, depending on their autistic or schizophrenic traits.
A new study builds on previous findings that demonstrate EEG recordings of the rostral anterior cingulate cortex can predict eventual response to treatments for depression.
A new study reports caffeine may worsen neuropsychiatric symptoms associated with Alzheimer's disease. Caffeine, researchers report, exacerbates neophobia, anxiety and cognitive flexibility in mouse models of the disease.
Researchers have identified a range of psychiatric disorders, including schizophrenia and autism, that share physical characteristics at the molecular level. Specifically, the study identifies common patterns of neural gene expression. In addition, researchers note important differences in gene expression that distinguish the disorders.
Researchers report brain alterations associated with heightened feelings of negative emotion and alienation in people who have a dependence on cannabis.
A new study reports different subtypes of bipolar disorder tend to cluster within families, suggesting that even though there are genetic similarities that indicate overlap between subtypes, each has a different origin.
A new study has identified rare genetic variation in the Thorase protein that causes the breakdown of receptors at the connections between neurons in the brain. The anti-epilepsy drug perampanel can help reverse anti-social behaviors linked to schizophrenia that are associated with this genetic variation.
University of Edinburgh researchers report many genes linked to neuroticism are also linked to depression. The findings may help to develop more personalized treatments with depressive disorders.
A major finding from researchers at Houston Methodist reveals a significant number of people diagnosed with schizophrenia or bipolar disorder may actually have a treatable immune system disorder. The condition causes NMDA receptors to stop functioning properly and can result in symptoms commonly associated with neuropsychiatric disorders.